Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gulam M Rather

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|April 27, 2019
A Novel Antibody-Toxin Conjugate to Treat Mantle Cell LymphomaGulam M Rather, Siang-Yo Lin, Hongxia Lin, et al.
Biomolecules|March 1, 2020
NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An OverviewAlvinsyah Adhityo Pramono, Gulam M Rather, Herry Herman, et al.
Biomedical Microdevices|May 23, 2024
Integrating optical and electrical sensing with machine learning for advanced particle characterizationMahtab Kokabi, Muhammad Tayyab, Gulam M Rather, et al.
Journal of Biomolecular Structure & Dynamics|September 14, 2023
Identification of novel scaffolds targeting SIRT3 through molecular modeling techniques for the treatment of Hepatocellular carcinomaCarlos Eliel Maya Ramírez, Zeeshan Shokat, Muhammad Sufyan, et al.
Scientific Reports|February 22, 2020
Rapid Assessment of Surface Markers on Cancer Cells Using Immuno-Magnetic Separation and Multi-frequency Impedance Cytometry for Targeted TherapyZhongtian Lin, Siang-Yo Lin, Pengfei Xie, et al.
Microsystems & Nanoengineering|October 25, 2019
Toward point-of-care assessment of patient response: a portable tool for rapidly assessing cancer drug efficacy using multifrequency impedance cytometry and supervised machine learningKaran Ahuja, Gulam M Rather, Zhongtian Lin, et al.
Oncotarget|June 15, 2018
Activated matriptase as a target to treat breast cancer with a drug conjugateGulam M Rather, Siang-Yo Lin, Hongxia Lin, et al.
Oncotarget|October 4, 2018
Modeling and antitumor studies of a modified L-penetratin peptide targeting E2F in lung cancer and prostate cancerTazeem Shaik, Gulam M Rather, Nitu Bansal, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|April 27, 2019
A Novel Antibody-Toxin Conjugate to Treat Mantle Cell LymphomaGulam M Rather, Siang-Yo Lin, Hongxia Lin, et al.
Biomolecules|March 1, 2020
NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An OverviewAlvinsyah Adhityo Pramono, Gulam M Rather, Herry Herman, et al.
Biomedical Microdevices|May 23, 2024
Integrating optical and electrical sensing with machine learning for advanced particle characterizationMahtab Kokabi, Muhammad Tayyab, Gulam M Rather, et al.
Journal of Biomolecular Structure & Dynamics|September 14, 2023
Identification of novel scaffolds targeting SIRT3 through molecular modeling techniques for the treatment of Hepatocellular carcinomaCarlos Eliel Maya Ramírez, Zeeshan Shokat, Muhammad Sufyan, et al.
Scientific Reports|February 22, 2020
Rapid Assessment of Surface Markers on Cancer Cells Using Immuno-Magnetic Separation and Multi-frequency Impedance Cytometry for Targeted TherapyZhongtian Lin, Siang-Yo Lin, Pengfei Xie, et al.
Microsystems & Nanoengineering|October 25, 2019
Toward point-of-care assessment of patient response: a portable tool for rapidly assessing cancer drug efficacy using multifrequency impedance cytometry and supervised machine learningKaran Ahuja, Gulam M Rather, Zhongtian Lin, et al.
Oncotarget|June 15, 2018
Activated matriptase as a target to treat breast cancer with a drug conjugateGulam M Rather, Siang-Yo Lin, Hongxia Lin, et al.
Oncotarget|October 4, 2018
Modeling and antitumor studies of a modified L-penetratin peptide targeting E2F in lung cancer and prostate cancerTazeem Shaik, Gulam M Rather, Nitu Bansal, et al.
Pageof 1